Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by JDavenporton Feb 24, 2022 10:13pm
162 Views
Post# 34460356

RE:RE:RE:RE:RE:Bidding war?

RE:RE:RE:RE:RE:Bidding war?Lol. You have no idea what you're talking about, beenthere. Denali started as a private company with venture capital backing, with the backing of major investment banks for its IPO, with hundreds of millions of dollars, and with over 100 employees. They had (and have) a leader, Dr. Ryan Watts, who ran Roche's Brain Shuttle program. Between all the players, they promoted the inferior F-Star technolgy to what we see today. 

And I know what Dr. Ryan Watts has said about Bioasis and xB3. My non-disclosure agreements prevent me from discussing it.

The question often arises about why hasn't Denali made an offer for Bioasis. Denali has a market cap of $4 billion, and it's been way higher than that. So, why?

If Denali made a bid for Bioasis either to eliminate xB3 as a competitor or to replace their TV with xB3, it would be an admission by Denali that its TV technology cannot compete with xB3. The Denali share price would then collapse. The Denali management and BoD would be sued for billions by Wall St. legal sharks. Denali would blow up.

Once Bioasis proves that xB3 is what Denali thinks it is, and what we believe it is, then the Bioasis share price should reflect what the market has thought of Denali.

It's all as simple as that.

jd
<< Previous
Bullboard Posts
Next >>